Explore Mutual Funds

Nippon India Pharma Fund(G)

As on Apr-02-2025 change fund
477.04  up3.00 (0.63%)
BUY

fund objective

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

riskometer

Investors understand that their principal will be at very high risk

5-Years History
financial year2024-20252023-20242022-20232021-20222020-2021
NAV in Rs (as on 31-Mar)481.27428.87270.59290.14250.18
Net Assets(Rs Crores) (as on 31-Mar) 7637.04 7125.28 4304.46 4931.89 4260.99
Scheme Returns(%)(Absolute)10.9458.24-6.8514.8377.36
B'mark Returns(%)(Absolute)NANANANANA
Category Rank30/10217/9065/7643/7532/75
Quarterly performance - Last 5 years (Absolute Ret. in %)
financial year Q1 Q2 Q3 Q4
2024-20254.0117.220.80-8.69
2023-202417.1011.2311.589.06
2022-2023-10.128.200.15-4.25
2021-202222.060.731.97-7.50
2020-202131.5919.5012.24-1.15
Top 10 holdings
company (%)
Sun Pharmaceutical Industries...13.68 
Divi's Laboratories Ltd.9.32 
Lupin Ltd.7.73 
Cipla Ltd.5.90 
Dr. Reddy's Laboratories Ltd.5.35 
Apollo Hospitals Enterprise Ltd.5.14 
Abbott India Ltd.3.82 
Vijaya Diagnostic Centre Ltd.3.41 
Medplus Health Services Ltd.3.39 
Glaxosmithkline Pharmaceutical...3.28 

Category

Sector Funds

Launch Date

05-Jun-04

Scheme Benchmark

NA

AUM ( in Cr.)

7,637.04

portfolio price to book value

7.37

investing style?

Large Growth

fund manager?

Sailesh Raj Bhan

expense ratio %

1.82

Top 10 sectors
sectors (%)
Pharmaceuticals & Drugs81.34
Hospital & Healthcare Services16.59
Business Support0.96

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

to go
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • maximum
performance comparison with similar schemes
scheme name investment style inception date AUM in Cr. 1Y(%) 3Y(%) 5Y(%) 10Y(%) since inception
Nippon India Pharma Fund(G)Large-Growth 05-Jun-20047,637.0410.2017.9427.5613.0220.38BUY
SBI Healthcare Opp Fund-Reg(G)Large-Growth 14-Jul-19993,312.8916.8522.2429.1410.8516.20BUY
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Large-Growth 13-Jul-20184,611.4717.0522.0530.56NA20.91BUY
Tata India Pharma & Healthcare Fund-Reg(G)Large-Growth 28-Dec-20151,103.9912.6518.4526.44NA11.96BUY
ITI Pharma & Healthcare Fund-Reg(G)Large-Growth 08-Nov-2021200.8312.9717.57NANA13.73BUY
Mirae Asset Healthcare Fund-Reg(G)Large-Growth 02-Jul-20182,441.1314.4817.2127.98NA20.87BUY
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Large-Growth 10-Jul-2019754.758.4616.6824.04NA20.39BUY
HDFC Pharma and Healthcare Fund-Reg(G)Large-Growth 04-Oct-20231,468.6826.92NANANA35.72BUY
WOC Pharma and Healthcare Fund-Reg(G)Large-Growth 06-Feb-2024271.3625.11NANANA22.14BUY
Kotak Healthcare Fund-Reg(G)Large-Growth 11-Dec-2023379.8710.98NANANA19.89BUY
Quant Healthcare Fund-Reg(G)Large-Growth 17-Jul-2023347.524.63NANANA22.23BUY
PGIM India Healthcare Fund-Reg(G)Large-Growth 06-Dec-202496.47NANANANA-7.70BUY
Bandhan BSE Healthcare Index Fund-Reg(G)Large-Growth 06-Sep-202415.97NANANANA-5.81BUY
Bajaj Finserv Healthcare Fund-Reg(G)Large-Growth 27-Dec-2024283.11NANANANA-9.86BUY
disclaimer

Finmoksha financial services, is an AMFI registered distributor with ARN No. 143367 through its proprietor Gopal Kumar Agrawal

The firm does not furnish any guaranties, warranties or representations, express or implied, on products offered through the Finmoksha platform. The firm accepts no liability for any damages or losses however caused, in connection with investments made through the platform. Terms and conditions of the platform are applicable at all times.

Mutual fund and other investments are always subject to market risks. Please read all, Scheme Information Documents (SID), Key Information Memorandum (KIM), Addendums (if any) issued thereto from time to time and any other related documents or information carefully before investing. Past performance is not indicative or assurance of future performance or returns. Please consider your specific investment requirements, risk appetite and time horizon before choosing a scheme of mutual fund or any other investment.

ARN No. 143367    

Copyrights © 2018 Finmoksha Financial Services. All Right Reserved
Designed, Developed & Content Powered By  Accord Fintech Pvt. Ltd.